LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells.

Foam cell formation is a key event in the onset and progression of atherosclerotic lesions. We have previously reported that internalization of aggregated low density lipoproteins (agLDLs) by vascular smooth muscle cells (VSMCs) produces cholesteryl ester (CE) accumulation in these cells. The aim of this study was to analyze whether the low density lipoprotein receptor-related protein (LRP) mediates the uptake of agLDL by VSMCs. First, immunocytochemistry and fluorescence microscopic analysis with the use of anti-LRP antibodies indicated that there was a high expression of LRP in VSMCs. Confocal microscopic analysis with the use of agLDLs labeled with fluorochrome 1,1'-dioctadecyl-3,3,3', 3'-tetramethylindocarbocyanine and anti-LRP antibodies showed the colocalization of agLDL and LRP. The second approach was to analyze the effect of LRP ligands on agLDL internalization; lactoferrin strongly inhibited CE accumulation from agLDLs (85.0+/-5.7% at 25 microg/mL) by impairing agLDL binding. Coincubation of agLDL with anti-LRP antibodies decreased in a dose-dependent manner agLDL-derived CE accumulation (from 20% at 12.5 microg/mL to 80% at 50 microg/mL). The third approach was to evaluate whether antisense LRP oligodeoxynucleotides were able to block agLDL internalization. Treatment of VSMCs with 5 micromol/L antisense LRP oligodeoxynucleotides reduced agLDL-derived CE accumulation by 84+/-2%. In conclusion, these results from immunologic, biochemical, and molecular interventions demonstrate that LRP mediates the binding and internalization of agLDL in human VSMCs. Because LRP is highly expressed in VSMCs and the uptake of 1 LDL aggregate amounts to the deposition of several hundreds of LDL particles, the uptake of agLDL through LRP could have a crucial role for lipid deposition in VSMCs.

[1]  M. Krieger,et al.  Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). , 1994, Annual review of biochemistry.

[2]  T. Nikkari,et al.  Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. , 1998, Circulation.

[3]  H. Pannekoek,et al.  Ligand-receptor interactions of the low density lipoprotein receptor-related protein, a multi-ligand endocytic receptor , 1998 .

[4]  U. Beisiegel,et al.  Hepatic lipase mediates the uptake of chylomicrons and beta-VLDL into cells via the LDL receptor-related protein (LRP). , 1996, Journal of lipid research.

[5]  V. Tertov,et al.  Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation. , 1992, Circulation research.

[6]  M. Brown,et al.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[7]  K. Williams,et al.  Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. , 1992, The Journal of biological chemistry.

[8]  V. Llorente,et al.  Prevention of cholesteryl ester accumulation in P388D1 macrophage-like cells by increased cellular vitamin E depends on species of extracellular cholesterol. Conventional heterologous non-human cell cultures are poor models of human atherosclerotic foam cell formation. , 1995, European journal of biochemistry.

[9]  R. E. Pitas,et al.  Expression of the acetyl low density lipoprotein receptor by rabbit fibroblasts and smooth muscle cells. Up-regulation by phorbol esters. , 1990, The Journal of biological chemistry.

[10]  U. Beisiegel,et al.  The LDL–receptor–related protein, LRP, is an apolipoprotein E-binding protein , 1989, Nature.

[11]  H F Hoff,et al.  Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[12]  A. Barrett,et al.  The electrophoretically 'slow' and 'fast' forms of the alpha 2-macroglobulin molecule. , 1979, The Biochemical journal.

[13]  S. Moestrup,et al.  Immunocytochemical identification of the human alpha 2-macroglobulin receptor in monocytes and fibroblasts: monoclonal antibodies define the receptor as a monocyte differentiation antigen. , 1990, Experimental cell research.

[14]  I. Mikhailenko,et al.  Low Density Lipoprotein Receptor-related Protein/-Macroglobulin Receptor Mediates the Cellular Internalization and Degradation of Thrombospondin , 1995, The Journal of Biological Chemistry.

[15]  V. Tertov,et al.  Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins. , 1989, Biochemical and biophysical research communications.

[16]  H. Goldenberg,et al.  Lactoferrin specifically inhibits endocytosis of chylomicron remnants but not alpha-macroglobulin. , 1992, The Journal of biological chemistry.

[17]  F. Kronenberg,et al.  Cellular uptake of lipoprotein[a] by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor-related protein. , 1997, Journal of lipid research.

[18]  E. Vilella,et al.  Lipoprotein lipase-mediated uptake of lipoprotein in human fibroblasts: evidence for an LDL receptor-independent internalization pathway. , 1996, Journal of lipid research.

[19]  M. Mims,et al.  Altered ultrastructural morphology of self-aggregated low density lipoproteins: coalescence of lipid domains forming droplets and vesicles. , 1991, Journal of lipid research.

[20]  J. Gliemann,et al.  Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands. , 1998, Biological chemistry.

[21]  J L Witztum,et al.  Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[22]  S. Eisenberg,et al.  Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. , 1992, The Journal of clinical investigation.

[23]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[24]  S. Damle,et al.  Binding of Low Density Lipoproteins by Proteoglycans Synthesized by Human Arterial Smooth Muscle Cells , 1993 .

[25]  D. Glancy,et al.  Macrophages stimulate cholesteryl ester accumulation in cocultured smooth muscle cells incubated with lipoprotein-proteoglycan complex. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[26]  V. Fuster,et al.  Coronary artery disease: pathogenesis and acute coronary syndromes. , 2001, The Mount Sinai journal of medicine, New York.

[27]  J. Herz.  The LDL-receptor-related protein ??? portrait of a multifunctional receptor , 1993 .

[28]  H F Hoff,et al.  A low density lipoprotein-sized particle isolated from human atherosclerotic lesions is internalized by macrophages via a non-scavenger-receptor mechanism. , 1986, Journal of lipid research.

[29]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (1). , 1992, The New England journal of medicine.

[30]  D. Steinberg,et al.  Enhanced Macrophage Uptake of Low Density Lipoprotein after Self‐Aggregation , 1988, Arteriosclerosis.

[31]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[32]  M. S. Brown,et al.  Proteolytic processing of the 600 kd low density lipoprotein receptor‐related protein (LRP) occurs in a trans‐Golgi compartment. , 1990, The EMBO journal.

[33]  L. Badimón,et al.  Differential cholesteryl ester accumulation in two human vascular smooth muscle cell subpopulations exposed to aggregated LDL: effect of PDGF-stimulation and HMG-CoA reductase inhibition. , 1999, Atherosclerosis.

[34]  M. Haumer,et al.  Removal of lactoferrin from plasma is mediated by binding to low density lipoprotein receptor‐related protein/α 2‐macroglobulin receptor and transport to endosomes , 1995, FEBS letters.

[35]  M. Brown,et al.  Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. , 1992, The Journal of biological chemistry.

[36]  D. L. Sokol,et al.  Nucleic acid therapeutics: state of the art and future prospects. , 1998, Blood.

[37]  K. Williams,et al.  Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation. , 1993, The Journal of biological chemistry.

[38]  M. Waknitz,et al.  Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans. , 1993, The Journal of biological chemistry.

[39]  S. Moestrup,et al.  The alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and beta-migrating very low density lipoprotein associated with the lipase. , 1993, The Journal of biological chemistry.

[40]  U. Steinbrecher,et al.  Mechanism of Uptake of Copper-oxidized Low Density Lipoprotein in Macrophages Is Dependent on Its Extent of Oxidation (*) , 1996, The Journal of Biological Chemistry.

[41]  S. Pizzo,et al.  Low-Density Lipoprotein Receptor-Related Protein/ α2-Macroglobulin Receptor on Murine Peritoneal Macrophages Mediates the Binding and Catabolism of Low-Density Lipoprotein , 1996 .

[42]  S. Moestrup,et al.  The human alpha 2-macroglobulin receptor contains high affinity calcium binding sites important for receptor conformation and ligand recognition. , 1990, Journal of Biological Chemistry.

[43]  P. Kovanen,et al.  Aggregation and fusion of modified low density lipoprotein. , 1996, Journal of lipid research.

[44]  T. Hayek,et al.  Lesioned low density lipoprotein in atherosclerotic apolipoprotein E-deficient transgenic mice and in humans is oxidized and aggregated. , 1995, Biochemical and biophysical research communications.

[45]  L. Badimón,et al.  Human and porcine smooth muscle cells share similar proliferation dependence on the mevalonate pathway: implication for in vivo interventions in the porcine model , 1996, European journal of clinical investigation.

[46]  D. Strickland,et al.  Sequence identity between the alpha 2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. , 1990, The Journal of biological chemistry.

[47]  S. L. Gonias,et al.  Activated alpha 2-macroglobulin and transforming growth factor-beta 1 induce a synergistic smooth muscle cell proliferative response. , 1993, Journal of Biological Chemistry.

[48]  T. Kodama,et al.  Expression of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein and scavenger receptor in human atherosclerotic lesions. , 1994, The Journal of clinical investigation.

[49]  M. Brown,et al.  Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[50]  S. Ylä-Herttuala,et al.  Expression of lipoprotein receptors in atherosclerotic lesions. , 1998, Atherosclerosis.

[51]  G. Bondjers,et al.  Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. , 1993, The Journal of biological chemistry.

[52]  R. E. Pitas,et al.  Synergistic Effects of Growth Factors on the Regulation of Smooth Muscle Cell Scavenger Receptor Activity (*) , 1995, The Journal of Biological Chemistry.

[53]  D. Dichek,et al.  Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice. , 1998, The Journal of clinical investigation.

[54]  M. Waknitz,et al.  The low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase. , 1992, The Journal of biological chemistry.

[55]  M. Alavi,et al.  Lipoprotein-proteoglycan complexes from injured rabbit aortas accelerate lipoprotein uptake by arterial smooth muscle cells. , 1994, Atherosclerosis.

[56]  L. Badimón,et al.  Esterified cholesterol accumulation induced by aggregated LDL uptake in human vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitors. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[57]  J. Rowley,et al.  Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. , 1993, Blood.

[58]  S. Moestrup,et al.  Analysis of ligand recognition by the purified alpha 2-macroglobulin receptor (low density lipoprotein receptor-related protein). Evidence that high affinity of alpha 2-macroglobulin-proteinase complex is achieved by binding to adjacent receptors. , 1991, The Journal of biological chemistry.